We discuss the existing data on anal precancers and demonstrate the impact of evidence gaps and uncertainty on a clinical decision model developed to provide clinical guidance for management of anal precancers.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771459 | PMC |
| http://dx.doi.org/10.1002/cncr.31033 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Anal cancer prevention: A field in need of scientific Advancement.
Virology
January 2025
Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; Department of Surgery, William S. Middleton Memorial Veteran's Hospital, Madison, WI, USA.
Despite the availability of several human papillomavirus (HPV) vaccines, the incidence of HPV-associated anal cancer is growing at a rate of 2.2% each year. As shown in results from the recent Phase III ANCHOR study, the treatment of high-grade anal lesions in people living with HIV (PLWH) can significantly reduce rates of anal cancer development compared to active surveillance alone.
View Article and Find Full Text PDFThe impact of Germany's human papillomavirus immunization program on HPV-related anogenital diseases: a retrospective analysis of claims data from statutory health insurances.
Arch Gynecol Obstet
November 2024
EU Real World Evidence, Xcenda GmbH, Lange Laube 31, 30159, Hanover, Germany.
Article Synopsis
- HPV is the most common sexually transmitted infection, and its vaccination has been part of Germany's national immunization program since 2007, but uptake rates are still low.
- A study analyzed healthcare claims data to assess the impact of this vaccination program on HPV-related diseases in women aged 28 to 33, comparing data from before and after the program's introduction.
- Results showed significant reductions in cervical precancers, anogenital warts, and vaginal precancer/cancer, indicating the vaccine's effectiveness and the potential benefits of increasing vaccination rates in Germany.
Association of Methylated DNA Markers with High-Risk HPV Infections in Oral Site and Precancer Anal Lesions in HIV-Positive MSM.
Biomedicines
August 2024
Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
Background: Human papillomavirus (HPV) infection is linked to several cancers, including anal and oral cancers. The incidence of anal cancer is particularly high among HIV-positive men who have sex with men (MSM). DNA methylation markers have shown promise as biomarkers for identifying precancerous lesions and cancer in HPV-infected individuals.
View Article and Find Full Text PDFSurgical protocols for oral leukoplakia and precancerous lesions across three different anatomic sites.
Oral Dis
August 2024
Oral Diagnosis Department, Piracicaba Dental School, State University of Campinas, Piracicaba, Brazil.
Article Synopsis
- A systematic review and meta-analysis evaluated the recurrence and progression risk of oral potentially malignant disorders (OPMD) and precancerous lesions after surgical treatments across various body sites.
- Twelve studies were included, revealing that the variation in surgical protocols and unclear margin descriptions affected clinical outcomes, particularly for oral leukoplakia and anal intraepithelial neoplasia.
- The analysis found no significant difference in recurrence risk between cold-knife and ablative treatments for oral leukoplakia and cervical intraepithelial neoplasia, highlighting the need for standardized surgical approaches.
Background: Non-AIDS defining malignancies present a growing challenge for persons with HIV (PWH), yet tailored interventions for timely cancer diagnosis are lacking. The Spanish IMPAC-Neo protocol was designed to compare two comprehensive cancer screening strategies integrated into routine HIV care. This study reports baseline data on the prevalence and types of precancerous lesions and early-stage cancer among participants at enrolment.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!